Blocking CD38 Using Anti-CD38 Fab2 To Protect NK Cells

Technology
E-133-2014
Patent ID
E-133-2014-0-IE-09
Country
IE
Application Type
EP
Patent Status
Issued
Patent Number
 
Publication Number
3154581
Application Number
15747597.1
IC
NHLBI
Date Filed
Date Issued
Patent PDF
 
Related Technologies
TAB-4504     Blocking CD38 using Daratumumab F(ab)2 to Protect Natural Killer Cells from Daratumumab-induced Apoptosis and Cell Death for the Treatment of Multiple Myeloma